bit bio

bit bio

Our breakthrough technology combines synthetic and stem cell biology, offering limitless possibilities. Enabling a new generation of cell therapies, providing the best human cells for research and drug discovery, and allowing the control of advanced synthetic biology circuits for biomanufacturing.

Contact bit bio via their website

News archive

11/02/2021 Welcomes New Chief Medical Officer Ramy Ibrahim...more
13/11/2020 published in Forbes...more
27/10/2020 published in The Times...more
27/10/2020 on a moonshot mission with London Institute for Mathematical Sciences...more
11/06/2020   bit bio secures $41.5m funding from top life sciences investors...more
26/02/2020   bit bio Secures Distribution Agreement with Abcam...more

11/12/2019   Charles River Announces Strategic Partnership with bit bio...more
01/12/2019   bit bio joins the BioPartner programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code